When the lipid-polymer hybrid nanoparticles enter the tumor tissue by EPR effects, the lipid layer is degraded by the overexpressed MMP-2 and the platelet antibody and dox-loaded inner core are released to mediate effects at different regions of the tumor microenvironment (Li et al., 2017b). Here, MMP2 is linked to neoplasm.